Lung function in relation to six-minute walk test in pulmonary hypertension

References

• Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC), European Respiratory Society (ERS), International Society of Heart and Lung Transplantation (ISHLT), Galiè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2009;34(6):1219–9.
   PubMed Web of Science ®Google Scholar
• Rubin LJ. Primary pulmonary hypertension. N Engl J Med. 1997;336(2):111–117.
   PubMed Web of Science ®Google Scholar
• Low AT, Medford AR, Millar AB, et al. Lung function in pulmonary hypertension. Respir Med. 2015;109(10):1244–1249.
   PubMed Web of Science ®Google Scholar
• Sun XG, Hansen JE, Oudiz RJ, et al. Pulmonary function in primary pulmonary hypertension. J Am Coll Cardiol. 2003;41(6):1028–1035.
   Web of Science ®Google Scholar
• Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med. 1987;107(2):216–223.
   PubMed Web of Science ®Google Scholar
• Jing ZC, Xu XQ, Badesch DB, et al. Pulmonary function testing in patients with pulmonary arterial hypertension. Respir Med. 2009;103(8):1136–1142.
   Web of Science ®Google Scholar
• Meyer FJ, Ewert R, Hoeper MM, et al. Peripheral airway obstruction in primary pulmonary hypertension. Thorax. 2002;57(6):473–476.
   Web of Science ®Google Scholar
• Gehlbach BK, Geppert E. The pulmonary manifestations of left heart failure. Chest. 2004;125(2):669–682.
   Web of Science ®Google Scholar
• Agostoni P, Magini A, Andreini D, et al. Spironolactone improves lung diffusion in chronic heart failure. Eur Heart J. 2005;26(2):159–164.
   Web of Science ®Google Scholar
• Wrobel JP, Thompson BR, Williams TJ. Mechanisms of pulmonary hypertension in chronic obstructive pulmonary disease: a pathophysiologic review. J Heart Lung Transplant. 2012;31(6):557–564.
   PubMed Web of Science ®Google Scholar
• Hughes JM, Pride NB. Examination of the carbon monoxide diffusing capacity (DL(CO)) in relation to its KCO and VA components. Am J Respir Crit Care Med. 2012;186(2):132–139.
   PubMed Web of Science ®Google Scholar
• Kaminsky DA, Whitman T, Callas PW. DLCO versus DLCO/VA as predictors of pulmonary gas exchange. Respir Med. 2007;101(5):989–994.
   Web of Science ®Google Scholar
• Fritz JS, Smith KA. The pulmonary hypertension consult: clinical and coding considerations. Chest. 2016. DOI:10.1016/j.chest.2016.05.010
   Google Scholar
• Benza RL, Gomberg-Maitland M, Miller DP, et al. The REVEAL registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension. Chest. 2012;141(2):354–362.
   PubMed Web of Science ®Google Scholar
• Kawut SM, Horn EM, Berekashvili KK, et al. New predictors of outcome in idiopathic pulmonary arterial hypertension. Am J Cardiol. 2005;95(2):199–203.
   Web of Science ®Google Scholar
• van der Lee I, Zanen P, Grutters JC, et al. van den Bosch JM. Diffusing capacity for nitric oxide and carbon monoxide in patients with diffuse parenchymal lung disease and pulmonary arterial hypertension. Chest. 2006;129(2):378–383.
   Web of Science ®Google Scholar
• Arena R, Guazzi M, Myers J, et al. Cardiopulmonary exercise testing in the assessment of pulmonary hypertension. Expert Rev Respir Med. 2011;5(2):281–293.
   PubMed Web of Science ®Google Scholar
• Babu AS, Myers J, Arena R, et al. Evaluating exercise capacity in patients with pulmonary arterial hypertension. Expert Rev Cardiovasc Ther. 2013;11(6):729–737.
   PubMedGoogle Scholar
• Meyer FJ, Lossnitzer D, Kristen AV, et al. Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension. Eur Respir J. 2005;25(1):125–130.
   PubMed Web of Science ®Google Scholar
• Miyamoto S, Nagaya N, Satoh T, et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2000;161(2 Pt 1):487–492.
   PubMed Web of Science ®Google Scholar
• Wensel R, Opitz CF, Anker SD, et al. Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing. Circulation. 2002;106(3):319–324.
   PubMed Web of Science ®Google Scholar
• Galie N, Manes A, Negro L, et al. A meta-analysis of randomized controlled trials in pulmonary arterial hypertension. Eur Heart J. 2009;30(4):394–403.
   PubMed Web of Science ®Google Scholar
• Sun XG, Hansen JE, Oudiz RJ, et al. Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation. 2001;104(4):429–435.
   PubMed Web of Science ®Google Scholar
• Fox BD, Langleben D, Hirsch A, et al. Step climbing capacity in patients with pulmonary hypertension. Clin Res Cardiol. 2013;102(1):51–61.
   Web of Science ®Google Scholar
• Galie N, Humbert M, Vachiery JL, et al. ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2015;46(4):903–975.
   PubMed Web of Science ®Google Scholar
• Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338.
   PubMed Web of Science ®Google Scholar
• Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J. 2005;26(3):511–522.
   PubMed Web of Science ®Google Scholar
• Standardized lung function testing. Report working party. Bull Eur Physiopathol Respir. 1983;19(Suppl 5):1–95.
   PubMedGoogle Scholar
• Laboratories ATSCoPSfCPF. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111–117.
   PubMed Web of Science ®Google Scholar
• Chetta A, Zanini A, Pisi G, et al. Reference values for the 6-min walk test in healthy subjects 20–50 years old. Respir Med. 2006;100(9):1573–1578.
   PubMed Web of Science ®Google Scholar
• Wedzicha JA. Domiciliary oxygen therapy services: clinical guidelines and advice for prescribers. Summary of a report of the Royal College of Physicians. J R Coll Physicians Lond. 1999;33(5):445–447.
   PubMedGoogle Scholar
• D’Alonzo GE, Bower JS, Dantzker DR. Differentiation of patients with primary and thromboembolic pulmonary hypertension. Chest. 1984;85(4):457–461.
   Web of Science ®Google Scholar
• Burke CM, Glanville AR, Morris AJ, et al. Pulmonary function in advanced pulmonary hypertension. Thorax. 1987;42(2):131–135.
   Web of Science ®Google Scholar
• Wasserman K, Zhang YY, Gitt A, et al. Lung function and exercise gas exchange in chronic heart failure. Circulation. 1997;96(7):2221–2227.
   PubMed Web of Science ®Google Scholar
• Breitling S, Ravindran K, Goldenberg NM, et al. The pathophysiology of pulmonary hypertension in left heart disease. Am J Physiol Lung Cell Mol Physiol. 2015;309(9):L924–41.
   Web of Science ®Google Scholar
• Soffler MI, Hayes MM, Schwartzstein RM. Respiratory sensations in dynamic hyperinflation: physiological and clinical applications. Respir Care. 2017;62(9):1212–1223.
   PubMed Web of Science ®Google Scholar
• Trip P, Nossent EJ, de Man FS, et al. Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses. Eur Respir J. 2013;42(6):1575–1585.
   PubMed Web of Science ®Google Scholar
• Farkhooy A, Janson C, Arnardottir RH, et al. Impaired carbon monoxide diffusing capacity is the strongest lung function predictor of decline in 12 minute-walking distance in COPD; a 5-year follow-up study. COPD. 2015;12(3):240–248.
   Google Scholar
• Rizzi M, Sarzi-Puttini P, Airoldi A, et al. Performance capacity evaluated using the 6-minute walk test: 5-year results in patients with diffuse systemic sclerosis and initial interstitial lung disease. Clin Exp Rheumatol. 2015;33(4 Suppl 91):S142–7.
   PubMed Web of Science ®Google Scholar
• Armstrong HF, Schulze PC, Bacchetta M, et al. Impact of pulmonary hypertension on exercise performance in patients with interstitial lung disease undergoing evaluation for lung transplantation. Respirology. 2014;19(5):675–682.
   Web of Science ®Google Scholar
• Glaser S, Noga O, Koch B, et al. Impact of pulmonary hypertension on gas exchange and exercise capacity in patients with pulmonary fibrosis. Respir Med. 2009;103(2):317–324.
   Web of Science ®Google Scholar
• Hosenpud JD, Stibolt TA, Atwal K, et al. Abnormal pulmonary function specifically related to congestive heart failure: comparison of patients before and after cardiac transplantation. Am J Med. 1990;88(5):493–496.
   PubMed Web of Science ®Google Scholar
• Malenfant S, Potus F, Mainguy V, et al. Impaired skeletal muscle oxygenation and exercise tolerance in pulmonary hypertension. Med Sci Sports Exerc. 2015;47(11):2273–2282.
   Web of Science ®Google Scholar
• Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 Suppl):D34–41.
   PubMed Web of Science ®Google Scholar
• Condliffe R, Kiely DG, Gibbs JS, et al. Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension. Eur Respir J. 2009;33(2):332–338.
   PubMed Web of Science ®Google Scholar